Youth Against Drugsin 419 -kampanja: Mieti vielä


[1 ] Lev-Ran, S., Roerecke, M., Le Foll, B. & George, T. P. 2013. The association between cannabis use and depression: a systemic review and meta-analysis of longitudinal studies. Psychological Medicine 44 (4): 797-810.

[2] Ksir, C. & Hart, C. L. 2016. Cannabis and psychosis: a critical overview of the relationship. Current Psychiatry Reports 18, article nro 12.

[3] Käypä hoito. 2018. Kannabiksen aiheuttamat terveyshaitat. Päivitetty 12.4.2018. Luettu 8.4.2020.

[4] Hudson, R., Renard, J., Norris, C., Rushlow, W. J. & Laviolette, S. R. 2019. Cannabidiol counteracts the psychotropic side-effects of Δ -9-tetrahydrocannabinol in the ventral hippocampus through bi-directional control of ERK1-2 phosphorylation. The Journal of Neuroscience 39 (44): 8762-8777.

[5] Niesink, R. J. M. & van Laar, M. W. 2013. Does cannabidiol protect against adverse psychological effects of THC? Frontiers in Psychiatry 2013 (4): 130.

[6] Justinová, Z., Redhi, G. H., Goldberg, S. R. & Ferré, S. 2014. Differential effects of presynaptic versus postsynaptic adenosine a24 receptor blockade on Δ -9-tetrahydrocannabinol (thc) self-administration in squirrel monkeys. The Journal of Neuroscience 34 (19): 6480-6484.

[7] Winstock, A. R. Cannabis: how to cut down or stop using. Global Drug Survey. Luettu 8.4.2020.

[8] Elkins, C. High tolerance to alcohol and drugs. Päivitetty 27.2.2020. Luettu 8.4.2020.

[9] WHO. 2020. Q&A on smoking and COVID-19. Päivitetty 24.3.2020. Luettu 8.4.2020.

[10] Ribeiro, L. & Ind, P. W. 2016. Effect of cannabis smoking on lung fuction and respiratory symptoms: a structured literature review. NPJ Primary Care Respiratory Medicine. Päivitetty 20.10.2016. Luettu 8.4.2020.

[11] Zorn, R. 2013. Reducing cannabis health harms. Matters of Substance 24 (4).

Oliko tämä hyödyllinen sivu?